Human Genome to get U.S. govt anthrax drug deal
Posted on: Monday, 3 October 2005, 00:32 CDT
WASHINGTON (Reuters) - Human Genome Sciences Inc. plans to announce a deal with the U.S. government on Monday to provide as many as 100,000 doses of an experimental anthrax drug, the Washington Post reported.
The Rockville, Maryland-based company will sell the government a third of an ounce of the drug for $1.8 million, an amount sufficient for government testers to compare the product with competitors, the paper said.
On Friday, U.S. officials awarded a similar contract to Winnipeg, Canada-based Cangene Corp. to supply its anthrax treatment product for a preliminary trial that could also lead to a larger order, the biotech firm said.
Cangene said its anthrax product, which is used to treat or prevent inhalation anthrax, had been picked for preliminary efficacy testing.
Under both contracts, the U.S. Department of Health and Human Services has an option to buy between 10,000 and 100,000 doses of the products.
Anthrax is an acute and sometimes deadly infectious disease caused by spore-forming bacterium that can be used as a biological weapon.
Letters laced with anthrax killed five people in the weeks that followed the September 11, 2001 attacks in New York and Washington, and many people were treated with strong antibiotics in case they had been infected. The cases have still not been solved.
Source: REUTERS
Related Articles
- Big Government Productions Presents Next Chapter in ACORN Sting
- DOR BioPharma Announces $940,000 FDA Orphan Products Grant for Clinical Development of RiVax(TM)
- 4imprint Awards Charitable Organizations $32,000 in Imprinted Products
- Verizon on Oregon Video Competition: 150,000 Washington County Households Move Closer to Real Choice for Cable TV
- Ritz Interactive, Inc. Adds Over 70,000 New Electronics Products to Online Shopping Sites
- Unicorp Expects to Begin Drilling Two Additional Wells on Its North Edna Prospect Within 60 Days. The Initial Well Drilled Tested at 175 BOPD or $4,725,000 Gross Annual Production
- Biophan Announces $1 Million Allocation in New Government Grants in Support of MYOTECH's MYO-VAD(TM); Plus $309,000 in Government Funded Equipment Provided in Support of Biophan Research
- More Than 250,000 Wholesale-Priced Products Available Through Product Sourcing Leader Doba; Inventory-Free Commerce Means Retail Without The Risk
- Unity Wireless Receives US$770,000 Order for Products to Support WiMax and Fixed Wireless Systems
- Deep Rock Completes First Well in Four-Well Project; Initial Tests Project 1,000,000 CF/Day Production Capability
 |
 |
User Comments (0)
RSS Feeds